Diabetes is a risk factor for the progression and prognosis of COVID-19
- PMID: 32233013
- PMCID: PMC7228407
- DOI: 10.1002/dmrr.3319
Diabetes is a risk factor for the progression and prognosis of COVID-19
Abstract
Backgound: To figure out whether diabetes is a risk factor influencing the progression and prognosis of 2019 novel coronavirus disease (COVID-19).
Methods: A total of 174 consecutive patients confirmed with COVID-19 were studied. Demographic data, medical history, symptoms and signs, laboratory findings, chest computed tomography (CT) as well the treatment measures were collected and analysed.
Results: We found that COVID-19 patients without other comorbidities but with diabetes (n = 24) were at higher risk of severe pneumonia, release of tissue injury-related enzymes, excessive uncontrolled inflammation responses and hypercoagulable state associated with dysregulation of glucose metabolism. Furthermore, serum levels of inflammation-related biomarkers such as IL-6, C-reactive protein, serum ferritin and coagulation index, D-dimer, were significantly higher (P < .01) in diabetic patients compared with those without, suggesting that patients with diabetes are more susceptible to an inflammatory storm eventually leading to rapid deterioration of COVID-19.
Conclusions: Our data support the notion that diabetes should be considered as a risk factor for a rapid progression and bad prognosis of COVID-19. More intensive attention should be paid to patients with diabetes, in case of rapid deterioration.
Keywords: COVID-19; diabetes; prognosis.
© 2020 The Authors. Diabetes/Metabolism Research and Reviews published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that they do not have any conflict of interest regarding this publication.
Figures



Comment in
-
Technology Gap Deepened by Coronavirus Pandemic.J Diabetes Sci Technol. 2020 Jul;14(4):774-775. doi: 10.1177/1932296820929390. Epub 2020 May 27. J Diabetes Sci Technol. 2020. PMID: 32460626 Free PMC article. No abstract available.
-
Serum amyloid A protein has been undervalued as a biomarker of COVID-19.Diabetes Metab Res Rev. 2021 Jan;37(1):e3376. doi: 10.1002/dmrr.3376. Epub 2020 Jul 18. Diabetes Metab Res Rev. 2021. PMID: 32588938 Free PMC article. No abstract available.
-
Diabetes and Covid-19: An interplay difficult to dissect.Diabetes Metab Res Rev. 2021 Jan;37(1):e3387. doi: 10.1002/dmrr.3387. Epub 2020 Aug 20. Diabetes Metab Res Rev. 2021. PMID: 32818297 Free PMC article. No abstract available.
Similar articles
-
Impact of glycemic control in diabetes mellitus on management of COVID-19 infection.Int J Diabetes Dev Ctries. 2020 Sep;40(3):340-345. doi: 10.1007/s13410-020-00868-7. Epub 2020 Sep 2. Int J Diabetes Dev Ctries. 2020. PMID: 32905072 Free PMC article.
-
Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.Front Immunol. 2021 Nov 10;12:745515. doi: 10.3389/fimmu.2021.745515. eCollection 2021. Front Immunol. 2021. PMID: 34858403 Free PMC article.
-
Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis.Ann Palliat Med. 2021 Feb;10(2):1928-1949. doi: 10.21037/apm-20-1863. Epub 2021 Jan 27. Ann Palliat Med. 2021. PMID: 33548996
-
Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19.Ann Transl Med. 2020 Nov;8(21):1449. doi: 10.21037/atm-20-3421. Ann Transl Med. 2020. PMID: 33313194 Free PMC article.
-
Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19.J Thromb Thrombolysis. 2021 May;51(4):941-946. doi: 10.1007/s11239-020-02270-w. J Thromb Thrombolysis. 2021. PMID: 32889620 Free PMC article.
Cited by
-
[Cardiovascular disorders in patients infected with 2019 novel coronavirus].Ann Cardiol Angeiol (Paris). 2021 Apr;70(2):106-115. doi: 10.1016/j.ancard.2020.11.004. Epub 2020 Nov 23. Ann Cardiol Angeiol (Paris). 2021. PMID: 33642045 Free PMC article. Review. French.
-
Caring for children and adolescents with type 1 diabetes mellitus: Italian Society for Pediatric Endocrinology and Diabetology (ISPED) statements during COVID-19 pandemia.Diabetes Res Clin Pract. 2020 Oct;168:108372. doi: 10.1016/j.diabres.2020.108372. Epub 2020 Aug 20. Diabetes Res Clin Pract. 2020. PMID: 32827594 Free PMC article. Review.
-
[Diabetes and COVID-19].Therapie. 2020 Apr 23:S0040-5957(20)30068-8. doi: 10.1016/j.therap.2020.04.004. Online ahead of print. Therapie. 2020. PMID: 33965234 Free PMC article. French.
-
Mechanism of higher risk for COVID-19 in diabetes: a mask to lift.Endocrine. 2020 Sep;69(3):477-480. doi: 10.1007/s12020-020-02423-0. Epub 2020 Jul 23. Endocrine. 2020. PMID: 32705411 Free PMC article.
-
Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73- Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes.Cells. 2020 Jul 22;9(8):1750. doi: 10.3390/cells9081750. Cells. 2020. PMID: 32707842 Free PMC article.
References
-
- Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin‐converting enzyme. Cloning and functional expression as a captopril‐insensitive carboxypeptidase. J Biol Chem. 2000;275(43):33238‐33243. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials